Novartis to cut 400 Irish jobs in ‘major blow’ to Irish pharma industry

The cost-saving cuts are set to impact staff working at the Novartis Global Service Center (NGSC) in Dublin, where most of company’s Ireland-based employees work.

Novartis facility in Ringaskiddy, which develops medicines through advanced therapy platforms and data science.

Pharmaceutical giant Novartis announced plans to cut its Irish workforce by a quarter, putting 400 jobs at risk.

Tánaiste and business minister Leo Varadkar said that "although the job losses are not unexpected", they will come as "a major blow to workers and their families".